ARCHIVES

Senate Markup Would Give NCI $985 Million, Offers Prospect That Reductions In Grants Will Be Restored

This article is from The Cancer Letter archive.

Vol. 08 No. 48 | December 10, 1982

Download PDF Visit The Full Archive

Related Articles

NCI Director Declines To Fund P-4 Breast Cancer Chemoprevention Trial.

June 22, 2007

Taxol Patents Reveal Bristol Strategy to Safeguard Market Against Competitors

July 4, 1997

NCAB, Hammer Agree On how 41 Billion To Be Handled: No String Attached

October 14, 1988

Rep. Wyden Questions NCI Motive For Choosing Not To Pursue RU 486

September 4, 1992

Hyperthermia Offers Prospects For Major Treatment Advance, Investigators Says

March 11, 1977

NCI-Approved Clinical Trials For The Month of June

June 24, 2011